5-134666901-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021982.3(SEC24A):c.644C>T(p.Ala215Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,613,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021982.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEC24A | NM_021982.3 | c.644C>T | p.Ala215Val | missense_variant | 3/23 | ENST00000398844.7 | NP_068817.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEC24A | ENST00000398844.7 | c.644C>T | p.Ala215Val | missense_variant | 3/23 | 2 | NM_021982.3 | ENSP00000381823 | P1 | |
SEC24A | ENST00000322887.8 | c.644C>T | p.Ala215Val | missense_variant | 3/13 | 1 | ENSP00000321749 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152118Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249268Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135268
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461608Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727138
GnomAD4 genome AF: 0.000151 AC: 23AN: 152236Hom.: 0 Cov.: 31 AF XY: 0.000188 AC XY: 14AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.644C>T (p.A215V) alteration is located in exon 3 (coding exon 3) of the SEC24A gene. This alteration results from a C to T substitution at nucleotide position 644, causing the alanine (A) at amino acid position 215 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at